CN101850078B - Chinese medicament for treating chronic nephritis - Google Patents

Chinese medicament for treating chronic nephritis Download PDF

Info

Publication number
CN101850078B
CN101850078B CN2009102358640A CN200910235864A CN101850078B CN 101850078 B CN101850078 B CN 101850078B CN 2009102358640 A CN2009102358640 A CN 2009102358640A CN 200910235864 A CN200910235864 A CN 200910235864A CN 101850078 B CN101850078 B CN 101850078B
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
chinese
chronic nephritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102358640A
Other languages
Chinese (zh)
Other versions
CN101850078A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Binjiang Urban Construction Investment Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102358640A priority Critical patent/CN101850078B/en
Publication of CN101850078A publication Critical patent/CN101850078A/en
Application granted granted Critical
Publication of CN101850078B publication Critical patent/CN101850078B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating chronic nephritis, and belongs to the field of Chinese medicaments for treating nephropathy. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as yerbadetajo herba ecliptae, glossy ganoderma, szechwon tangshen root, medicinal indianmulberry root, Chinese angelica, radix pseudo-ginseng, Indian buead, coix seed and the like. The Chinese medicament has the effects of supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, tonifying the spleen and the kidney and inducing diuresis to reduce edema, and has the advantages of obvious effect, definite curative effect and quick response.

Description

一种治疗慢性肾炎的中药A kind of traditional Chinese medicine for treating chronic nephritis

技术领域technical field

本发明属于治疗肾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating nephropathy.

背景技术Background technique

目前旨在治疗慢性肾炎的中药领域,存在两个方面的缺点:其一,效果不够明显;其二,见效比较迟缓,大批慢性肾炎患者因药物不能有效地缓解肾病特有的严重乏力、水肿、蛋白尿、肾功能异常,病情不断发展而成为肾衰竭,患者及其家属对此很不满意。At present, there are two shortcomings in the field of traditional Chinese medicine aimed at treating chronic nephritis: one, the effect is not obvious enough; Urinary and renal function abnormalities, the condition continued to develop and became renal failure, the patient and his family were very dissatisfied with this.

针对以上提出的问题,本发明提供一种治疗慢性肾炎的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a kind of traditional Chinese medicine for treating chronic nephritis, which can solve the problem that the effect of traditional Chinese medicine is not obvious enough and the effect is relatively slow in the past. The advantage of quicker results.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗慢性肾炎的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of chronic nephritis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

旱莲草4-30份    灵芝2-12份    党参4-30份Eclipta 4-30 parts Ganoderma lucidum 2-12 parts Codonopsis 4-30 parts

巴戟天4-30份    当归4-30份    三七3-20份Morinda officinalis 4-30 parts Angelica 4-30 parts Panax notoginseng 3-20 parts

茯苓4-30份      薏苡仁5-40份Poria cocos 4-30 parts Coix seed 5-40 parts

这种治疗慢性肾炎的中药是由下列方法制成的:This traditional Chinese medicine for treating chronic nephritis is made by the following method:

(1)按上述重量比,将旱莲草、党参、巴戟天、当归、茯苓、薏苡仁经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Eclipta, Codonopsis, Morinda officinalis, Angelica, Poria, Coix seed are extracted by conventional water extraction process to make extract powder;

(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。中医认为,慢性肾炎多由急性肾炎演变而来,临床易出现脾肾两虚型,治当温补肾阳以消肿,标本兼施。方中巴戟天温补肾阳;灵芝、党参健脾补气;茯苓、薏苡仁利尿消肿;合以旱莲草益肾;当归、三七养血活血化瘀,加强肾组织微循环。诸药配伍,相得益彰,共奏益气养血,活血化瘀,健脾益肾,利尿消肿之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. According to traditional Chinese medicine, chronic nephritis is mostly evolved from acute nephritis, and the deficiency of spleen and kidney is prone to occur clinically. In the prescription, Morinda officinalis warms and nourishes kidney yang; Ganoderma lucidum and Codonopsis invigorate spleen and qi; Poria cocos and coix seed diuresis and reduce swelling; combined with eclipse grass to nourish kidney; angelica and notoginseng nourish blood, activate blood and remove blood stasis, and strengthen renal tissue microcirculation. All the medicines are compatible and complement each other, and play the functions of nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, invigorating the spleen and kidney, diuresis and reducing swelling, with good effect and quick effect.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

旱莲草80克    灵芝芝40克  党参80克Eclipta 80g Ganoderma lucidum 40g Codonopsis 80g

巴戟天80克    当归80克    三七60克Morinda officinalis 80g Angelica 80g Panax notoginseng 60g

茯苓80克      薏苡仁100克Poria cocos 80 grams Coix seed 100 grams

按规定重量,用常规水提取工艺将旱莲草、党参、巴戟天、当归、茯苓、薏苡仁提取,制成浸膏细粉150克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊892粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract Eclipta, Codonopsis, Morinda officinalis, Angelica, Poria cocos and coix seed with conventional water extraction process to make 150 grams of extract powder, and grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, and mix with the above The fine powder of the extract is mixed, stirred evenly, made into fine granules, packed into No. 0 capsules, and made into 892 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (the weight is in grams):

旱莲草160克    灵芝80克     党参160克Eclipta 160g Ganoderma lucidum 80g Codonopsis 160g

巴戟天160克    当归160克    三七100克Morinda officinalis 160g Angelica 160g Panax notoginseng 100g

茯苓160克      薏苡仁200克Poria cocos 160g Coix seed 200g

按上述同样的方法,制成中药胶囊1714粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1714 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

旱莲草300克    灵芝120克    党参300克Eclipta 300g Ganoderma lucidum 120g Codonopsis 300g

巴戟天300克    当归300克    三七200克Morinda officinalis 300g Angelica 300g Panax notoginseng 200g

茯苓300克      薏苡仁400克Poria cocos 300g Coix seed 400g

按上述同样的方法,制成中药胶囊3178粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 3178 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

旱莲草8份    灵芝4份    党参8份8 parts of Eclipta, 4 parts of Ganoderma lucidum, 8 parts of Codonopsis

巴戟天8份    当归8份    三七6份8 parts of Morinda officinalis, 8 parts of Angelica, 6 parts of Panax notoginseng

茯苓8份      薏苡仁10份Poria cocos 8 parts Coix seed 10 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

旱莲草25份    灵芝9份     党参25份Eclipta 25 parts Ganoderma lucidum 9 parts Codonopsis 25 parts

巴戟天25份    当归25份    三七15份Morinda officinalis 25 parts Angelica 25 parts Panax notoginseng 15 parts

茯苓25份      薏苡仁35份Poria cocos 25 parts Coix seed 35 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医慢性肾炎为例,经6例临床观察。选择中医诊断慢性肾炎为标准:肾病迁延,肢体乏力;眼睑、下肢常有水肿;经常有蛋白尿、血尿;肾功能受损。如上症状,即可确诊。在确诊观察的对象中,男性2例,女性4例,无其它严重疾病,年龄为42岁-71岁,平均年龄57.3岁。The present invention takes chronic nephritis of traditional Chinese medicine as an example, through 6 cases of clinical observation. TCM diagnosis of chronic nephritis was selected as the standard: persistent nephropathy, limb weakness; eyelids, lower limbs often have edema; often proteinuria, hematuria; renal function impairment. The above symptoms can be diagnosed. Among the objects confirmed and observed, there were 2 males and 4 females, without other serious diseases, aged 42-71 years, with an average age of 57.3 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲;水肿明显缓解、消失;蛋白尿、血尿减少;检查肾功能指标改善。1. Significant effect: Physical fitness is enhanced, body is strong; edema is obviously relieved and disappears; proteinuria and hematuria are reduced; renal function indicators are improved.

2、有效:体质增强,身上有劲;水肿、蛋白尿、血尿等有所缓解。2. Effective: Physical fitness is enhanced, body is strong; edema, proteinuria, hematuria, etc. are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察6个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用6个月后,症状明显改善。临床实验的6人中,显效3人,有效2人,无效1人,总有效率83.3%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 6 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 6 months of taking, Symptoms improved significantly. Among the 6 people in the clinical trial, 3 people were markedly effective, 2 people were effective, and 1 person was ineffective, and the total effective rate was 83.3%.

Claims (1)

1. a Chinese medicine for the treatment of chronic nephritis adopts the raw material of Chinese medicine preparation, and weight ratio is:
Herba Ecliptae 4---30 parts of 30 portions of Ganodermas 2---12 parts of Radix Codonopsis 4---
Radix Morindae Officinalis 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
40 parts in Poria 4---30 parts of Semen Coiciss 5---
The Chinese medicine of this treatment chronic nephritis is made by following method:
(1) by above-mentioned weight ratio, Herba Ecliptae, Radix Codonopsis, Radix Morindae Officinalis, Radix Angelicae Sinensis, Poria, Semen Coicis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102358640A 2009-10-28 2009-10-28 Chinese medicament for treating chronic nephritis Expired - Fee Related CN101850078B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102358640A CN101850078B (en) 2009-10-28 2009-10-28 Chinese medicament for treating chronic nephritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102358640A CN101850078B (en) 2009-10-28 2009-10-28 Chinese medicament for treating chronic nephritis

Publications (2)

Publication Number Publication Date
CN101850078A CN101850078A (en) 2010-10-06
CN101850078B true CN101850078B (en) 2011-07-20

Family

ID=42801868

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102358640A Expired - Fee Related CN101850078B (en) 2009-10-28 2009-10-28 Chinese medicament for treating chronic nephritis

Country Status (1)

Country Link
CN (1) CN101850078B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768404B (en) * 2014-01-09 2016-05-11 国长峰 A kind of Chinese medicine composition for the treatment of type of YIN-deficiency and interior-heat IgA ephrosis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129707A (en) * 2007-08-30 2008-02-27 尹克山 Traditional Chinese medicine for treating chronic nephritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129707A (en) * 2007-08-30 2008-02-27 尹克山 Traditional Chinese medicine for treating chronic nephritis

Also Published As

Publication number Publication date
CN101850078A (en) 2010-10-06

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN101843723B (en) Chinese medicament for treating abnormal menstruation
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101406566B (en) Chinese medicine for treating gastric cancer
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101850078A (en) A kind of traditional Chinese medicine for treating chronic nephritis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101850020B (en) Chinese medicament for treating chronic kidney failure
CN101843734B (en) Chinese medicament for treating abnormal menstruation
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843816B (en) Chinese medicament for treating chronic nephritis
CN101843756B (en) Chinese medicament for treating chronic nephritis
CN101843818B (en) Chinese medicament for treating chronic nephritis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101391072B (en) A kind of traditional Chinese medicine for treating diabetic diarrhea
CN101843870B (en) Chinese medicament for treating diabetic acro-necrosis
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101874870B (en) Traditional Chinese medicine for treating chronic hepatitis
CN101843744B (en) A kind of traditional Chinese medicine for treating chronic renal failure
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843864A (en) Chinese medicament for treating diabetic acro-necrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

Termination date: 20151028

EXPY Termination of patent right or utility model